COVID-19 & much more in our latest Industry Update
Articles filtered by tag
Science Will Prevail: Vaccines, BCs & COVID-19
AJ de Montjoie reflects on the CDISC Interchange and reviews the main presentations.
Swiss-exit, Turkey-exit, BREXIT and Medical Device Regulation
Swiss-exit, Turkey-exit, BREXIT and Medical Device Regulation
Regulations & Guidance: Clinical Trials
Q1’s Industry Insights round up all the latest regulatory news
Clinical Trials News and Regulations
Our latest Industry Update finishes the year focusing on COVID-19 & BREXIT
Clinical Trials News from around the Globe
All the latest regulatory updates compiled for you by S-cubed.
EMA Publishes Updated Guidance on Nitrosamines Impurities
Latest news from EMA regarding nitrosamines
Marketing Authorisation Holder GMP-related Responsibilities
Our latest regulatory update focuses on the responsibilities of the Marketing Authorisation Holder.
Clinical Development Practices & Regulations
Our latest Industry Update for Q2 covers the latest regulatory information around COVID-19 and much more.
COVID-19: European Medicines Agency Updates
Latest updates from EMA in response to the COVID-19 pandemic.
Nitrosamine Risk Evaluation for Marketing Authorisation Holders
The deadline for Nitrosamine Risk Evaluation is looming. Are you ready?
Clinical Trial Regulation, ICH E6(R2) & Brexit
Our first Industry Update of 2020 focuses on Clinical Trial Regulation, Brexit and the latest from FDA & EMA.